Join the conversation

Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Loading...Loading...Loading...Loading...

Trending Tickers

SLS logo
Top trending tickerSLS
$8.32
5.85%
#1
SELLAS is drawing attention ahead of the Phase 3 REGAL trials GPS survival readout in AML, which entered final analysis after reaching its 80-death trigger. Bulls speculate about a positive result, a potential buyout, and short covering, while skeptics stress the binary-trial risk and recent weakness; talk of data leaks remains unconfirmed.
CAPR logo
CAPR
$8.14
14.59%
#2
Capricors FDA decision on Deramiocel for Duchenne muscular dystrophy dominates discussion, with traders divided over whether the amended applications upper-limb data can overcome concerns about the statistical analysis, the prior CRL and the advisory-panel vote. Summit Therapeutics rejection has heightened nerves amid the selloff, though many traders argue the cases are not comparable.
INFQ logo
INFQ
$8.06
4.95%
#3
Infleqtions quarterly report is driving debate: revenue fell short of expectations and losses widened, while the company maintained its full-year guidance and highlighted its cash position and quantum milestones. Traders are split between seeing those positives as support for the long-term thesis and worrying about growth, cash burn, and weakness across quantum and small-cap tech stocks.
UAL logo
UAL
$109.00
0.28%
#4
A reported widespread United system outage disrupting departing flightsfollowing a recent FAA communications failure and nationwide ground stopis driving concern about operational disruption. Traders debate whether the setback is a buying opportunity or another reason for caution; cyberattack claims remain speculation, with some posts describing it as a technical glitch.
OMER logo
OMER
$15.21
13.04%
#5
Omeross latest quarterly results showed continued YARTEMLEA sales growth and positive operating cash flow, but the shares sold off after the report. Traders are split between seeing strong launch momentum and a positive outlook versus arguing expectations were higher and focusing on the GAAP loss and funding concerns.
JPM logo
JPM
$337.50
2.51%
#6
JPMorgans reported transaction delays, attributed by the bank to a software bug, are driving discussion; traders are debating cyberattack rumors, though there is no confirmed evidence of an attack. The concerns coincide with weakness across bank stocks and a broader market decline.
BAC logo
BAC
$50.12
1.77%
#7
Reported online-banking disruptions at Bank of America and several other major banks are driving concern about customers ability to access accounts and transfer funds. Some traders speculate about cyberattacks or broader banking stress, but the cause of the disruptions is not established in the discussion.
NOK logo
NOK
$7.40
8.30%
#8
Nokia is drawing attention as shares extend a steep post-earnings slide, with traders citing weakness across AI-related stocks and reports that Nvidia reduced its Nokia holdings as reasons for the pressure. The community is largely bearish on the continuing decline, though some investors argue Nokias AI-networking, telecom, and defense opportunities support a longer-term case.
HELP logo
HELP
$7.68
13.42%
#9
Helus Pharmas HLP003 met its primary endpoint in a Phase 3 depression trial, but shares sold off as traders focused on three treatment-related serious adverse events, including a suicide attempt, and sought more safety detail. The community is split between viewing the efficacy as strong and the safety concerns as unresolved, with financing and dilution worries adding pressure.
DIS logo
DIS
$118.47
0.42%
#10
Disney is drawing attention ahead of its quarterly earnings report, with traders focused on streaming profitability, parks performance and the FY27 outlook. Some expect cost discipline and buybacks to support a turnaround, while others worry about revenue and parks demand and note the stocks struggle around resistance.

About Stocktwits

With over 10 million users, Stocktwits helps you tap into the real-time sentiment and trending insights across stocks, ETFs, and crypto.